Plain-English translation of NCT05536349 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Leukemia research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a combination of three medications—, , and —given together to treat chronic lymphocytic leukemia (a type of blood cancer) in patients who have never received treatment before. The goal is to see if this medication combination can help the cancer go away or become undetectable in the blood. Researchers want to understand how well this treatment works and whether patients can tolerate it safely.
Chronic lymphocytic leukemia is a serious blood cancer that typically requires treatment. This trial exists to find out if combining three different medications—each with different ways of fighting cancer cells—might work better together than any single medication alone, giving patients a better chance at long-term remission.
You likely qualify if…
You likely don't qualify if…
You will take all three medications by mouth in 28-day treatment cycles. You will need to visit the clinic regularly for blood tests and checkups to monitor how you are responding to the treatment and to check for any side effects. The study will track your health over time, including whether your cancer becomes undetectable, how long you stay in remission, and how well you tolerate the medication combination.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
United States